[if gte mso 9] > < xml >
hospital pharmacists are formed in the process ofauthorisation, registration and pricing of medicines
60 specialists gather in Murcia in a dayTraining
-the objectiveis specialists make a sunset on the day of the training dayon the procedures involved in the stages prior to themarketing of drugs.
-the workshopIt has a practical methodology and its intention is to move to the environmentHospital decision-making that takes place in the State field.
-the course Registration, authorization, funding and fixing of prices of medicinesin Spain ”, promoted by the company Takeda, is aimed at pharmacists ofHospital.
Murcia, 2012-may To know what decisions were carried out at the levelCentral in the field of pharmaceuticals is the objective of thetraining day registration, licensing, financing and price fixingof drugs in Spain ”, a workshop aimed at pharmacists in hospitalintended to deepen the knowledge of these specialists onmatter.The course, heldrecently in Murcia and promoted by Takeda, has brought together a total of 60hospital pharmacists.
says D. Pedro Gómez Pajuelo, Assistant Director-GeneralDeputy of the General Secretary of the Instituto Carlos III and one of the speakersof the workshop, the goal of the day is move to the hospital environment decision-makingdecision that takes place at the State level, as well as deepen in thefunctioning of decision-making at the central State level bodies ”.
in this economic process which we are living, increasinglyIt has more importance well knowing the process of authorization and setting ofprices ”, says Gómez Pajuelo.TheWorkshop is directed at both hospital pharmacists for pharmacists as ofother areas and whose responsibility includes directly or indirectly theevaluation of medicinal products or the analysis of pharmaceutical prescription.
j decorated information: update
DRA. Nativity Calvente, head of unit area ofFunding of research (directorate general of pharmacy) of the MinistryHealth, Social Affairs and equality, and another of the speakers at the meeting,says that is good hospital pharmacists to participate in thesetraining sessions ” that allow to have a update ” in thisarea.With regard to differences withinof the Member States, the DRA. Calvente says that each time there is a greaterconvergence to authorize medicines and quality requirements arethey are combining and harmonizing within all areas ”.
the workshop attendees can deepen in theknowledge of the current procedure of pricing, which involves theauthorisation of medicines by the Spanish medicines agency.The ongoing addition, hospital pharmacists have been trained onthe mechanism of work, strategies and criteria of the governing body, the CommissionInterministerial price, when it comes to evaluate drugs and adoptconcrete decisions.
methodology: assessment of case studies
the workshop boasts a practical methodology to ensure that theattendees have the opportunity to do a practical course in whichThey carried out an evaluation of the dossier of a case, which must reel off theirweaknesses and strengths. trying toput on it most of the difficulties that canfind ”, explains Pedro Gómez.
Welcome to the day have led out Dr.Pedro GarcÃa Salom, Member of the levante area of the Spanish society of hospital pharmacy(Spanish), and DRA. Mª Carmen Mira Sirvent, Chief of the pharmacy service of theHospital Sta. Lucia de Cartagena.Thefirst presentation was given by DRA. Nativity Calvente, under the title Registration of drugs: centralised procedure – EMEA, national registry –AEM, record decentralised or mutual recognition ”.The second operation was carried out by ofPedro Gómez Pajuelo, who gave the talk system / procedure ofpricing on new trends (context) and Spain (past and present)(European) ”.The workshop was held theHall of acts of the Hospital General Universitario Santa Lucia Cartagena(Murcia).
About Takeda Pharmaceutical Spain
Takeda Pharmaceutical Spain, located in Madrid, is theSpanish organisation for marketing and sales of Takeda Pharmaceutical CompanyLimited.
as Japan largest pharmaceutical company and one of theleading companies of the industry, the Mission of Takeda is directing its effortsto improve the health of patients around the world through an innovationleader in the field of medicine.Thecompany has a commercial presence in over 70 countries, with particularfortress in Asia, North America, Europe and emerging markets as fastgrowth such as Latin America, Russia-CIS and China.Takeda ranked number 12 in theworld ranking of pharmaceutical companies, number 14 in the BRIC countries(Brazil, Russia, India and China) and 18 in Europe.The commercial presence of Takeda coversmainly the therapeutic areas of metabolic diseasesGastroenterology, Oncology, cardiovascular health, diseases of the systemcentral nervous, inflammatory and immune disorders, diseasesrespiratory and pain management.
